An inflammatory eruption associated with recombinant human IL‐6

Academic Article

Abstract

  • Interleukin 6 (IL‐6) is an endogenous cytokine with multiple biological functions, including amplification of the inflammatory response. Recombinant human IL‐6, administered as part of a chemotherapeutic regimen, has recently been shown to cause regression of certain types of malignant tumours. We report a patient who developed a cutaneous eruption consisting of coalescent, erythematous, scaling macules and papules after administration of recombinant human IL‐6, given as part of her chemotherapy for ductal carcinoma of the breast. Copyright © 1994, Wiley Blackwell. All rights reserved
  • Published In

    Digital Object Identifier (doi)

    Author List

  • FLEMING TE; MIRANDO WS; SOOHOO LF; COOPER BW; ZAIM MT; LAZARUS HM; ELMETS CA
  • Start Page

  • 534
  • End Page

  • 536
  • Volume

  • 130
  • Issue

  • 4